|
Dec 7
|
Is AbbVie Stock a Buy Now?
|
|
Dec 6
|
AbbVie to Buy Cerevel Therapeutics for $8.7 Billion
|
|
Dec 6
|
ImmunoGen (IMGN) Gets FDA Priority Review for Elahere sBLA
|
|
Dec 5
|
FDA Grants Priority Review of ImmunoGen’s Supplemental Biologics License Application for ELAHERE® (mirvetuximab soravtansine-gynx) in Platinum-Resistant Ovarian Cancer
|
|
Dec 4
|
Are You Looking for a Top Momentum Pick? Why ImmunoGen (IMGN) is a Great Choice
|
|
Dec 3
|
12 Stocks Billionaire Steve Cohen Just Bought and Sold
|
|
Dec 1
|
ImmunoGen (IMGN) Just Flashed Golden Cross Signal: Do You Buy?
|
|
Dec 1
|
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
|
|
Dec 1
|
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
|
|
Dec 1
|
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
|
|
Dec 1
|
Why Abbvie Stock Popped Today
|
|
Nov 30
|
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
|
|
Nov 30
|
AbbVie to acquire ImmunoGen in $10B deal
|
|
Nov 30
|
Rebel's Edge - November 30: $IMGN, $CRM, $VFS, and the Aaron Rogers Question
|
|
Nov 30
|
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio
|
|
Nov 30
|
ImmunoGen Stock Soars 81% on AbbVie’s $10.1 Billion Takeover
|
|
Nov 30
|
AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion
|
|
Nov 30
|
Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout
|
|
Nov 30
|
ImmunoGen (IMGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Nov 30
|
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio
|